Evaluation of treatment benefit in journal of clinical oncology

Journal of Clinical Oncology

Volumn 31, Issue 9, 2013, Pages 1123-1124

  Goodwin, Pamela J ^a   Ballman, Karla V ^b   Small, Eric J ^c   Cannistra, Stephen A ^d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CANCER THERAPY; EDITORIAL; HUMAN; MEDICAL LITERATURE; META ANALYSIS (TOPIC); ONCOLOGY; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

EVALUATION STUDIES AS TOPIC; HUMANS; MEDICAL ONCOLOGY; PERIODICALS AS TOPIC; TREATMENT OUTCOME;

EID: 84875974510     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.6952     Document Type: Editorial

References (6)

1. Byar DP: Why data bases should not replace randomized clinical trials. Biometrics 36:337-342, 1980
2. Levine MN, Julian JA: Registries that show efficacy: Good, but not good enough. J Clin Oncol 26:5316-5319, 2008
3. Patsopoulos NA: A pragmatic view on pragmatic trials. Dialogues in Clinical Neuroscience 13:217-224, 2011
4. Sox HC, Greenfield S: Comparative effectiveness research: A report from the Institute of Medicine. Ann Intern Med 151:303-205, 2009
5. Verweij J, Disis ML, Cannistra SA: Phase I studies of drug combinations. J Clin Oncol 30:4545-4546, 2010
6. Cannistra S: Phase II trials in Journal of Clinical Oncology. J Clin Oncol 27:3073-3076, 2009